id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-D-4693-0023,FDA,FDA-2018-D-4693,Postapproval Pregnancy Safety Studies; Guidance for Industry,Other,Guidance,2026-05-11T04:00:00Z,2026,5,2026-05-11T04:00:00Z,,2026-05-11T17:39:45Z,,1,0,09000064b92cf3d6
FDA-2018-D-4693-0022,FDA,FDA-2018-D-4693,Postapproval Pregnancy Safety Studies; Guidance for Industry; Availability,Notice,Notice of Availability,2026-05-11T04:00:00Z,2026,5,2026-05-11T04:00:00Z,,2026-05-11T17:36:17Z,2026-09268,0,0,09000064b92cf982
FDA-2018-D-4693-0002,FDA,FDA-2018-D-4693,Postapproval Pregnancy Safety Studies; Guidance for Industry; Draft Guidance,Other,Guidance,2019-05-09T04:00:00Z,2019,5,2019-05-09T04:00:00Z,,2024-11-12T23:00:23Z,,1,0,0900006483c4bb1a
FDA-2018-D-4693-0001,FDA,FDA-2018-D-4693,Postapproval Pregnancy Safety Studies; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2019-05-09T04:00:00Z,2019,5,2019-05-09T04:00:00Z,2019-07-09T03:59:59Z,2019-07-10T01:01:39Z,2019-09527,0,0,0900006483c4af3d